Notably, in three of the seven patients that carried the NMD mutations in CHD1L, DPF2 and BRD7, the genes were down-regulated in these tumor tissues while the same genes in the other patients showed significant up-regulation (FDR < 0.05) (Additional file 1: Figure S4A–C). This evidence concerns the gene CHD1L and neoplasm.